Physician profile
Greg D Parker
NPI 1073574687
$6,749.65
in general payments reported to CMS, 2019-2025
41 companies · $1,396 in 2025
The $1,396 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,284 · 2022: $1,287 · 2023: $1,477 · 2024: $1,306 · 2025: $1,396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,093 · Education: $86.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,092.69 |
| Education | $86.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,077.78 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $611.74 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $546.75 | 2021-2025 | Freestyle Libre |
| Amgen INC. | $515.56 | 2021-2025 | Evenity, Repatha, Prolia |
| Sumitomo Pharma America, INC. | $457.52 | 2023-2025 | Gemtesa |
| Novo Nordisk INC | $414.52 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $378.94 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Lundbeck LLC | $259.54 | 2023-2025 | Rexulti |
| Abbvie INC. | $243.38 | 2021-2025 | |
| Astellas Pharma US INC | $231.89 | 2021-2023 | Myrbetriq |
| Otsuka America Pharmaceutical, INC. | $216.11 | 2022-2025 | Rexulti, Nuedexta |
| Exact Sciences Corporation | $159.90 | 2023-2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $154.77 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $150.17 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $150.05 | 2021-2024 | Gvoke Hypopen |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Greg Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.